Literature DB >> 8418195

Function of B cells expressing a human immunoglobulin M rheumatoid factor autoantibody in transgenic mice.

H Tighe1, P P Chen, R Tucker, T J Kipps, J Roudier, F R Jirik, D A Carson.   

Abstract

We have generated transgenic mice that express the immunoglobulin (Ig)M heavy chain and kappa light chain genes coding for a human IgM rheumatoid factor (RF), Les. Transgenic B cells expressing human IgM RF show striking similarities to their counterparts in normal humans. They comprise a significant proportion of the adult B cell population, but secrete only low levels of RF into the serum. The RF transgene-expressing B cells localize to primary B cell follicles and the mantle zone regions of secondary follicles in the spleen. Using these mice we have been able to show that one of the central functions of normal RF-expressing B cells may be to act as highly efficient antigen-presenting cells for low concentrations of immune-complexed antigen. High levels of secretion of IgM RF can not be induced under normal circumstances, although RF-expressing B cells proliferate well in vitro to both aggregated human IgG and anti-human IgM antibodies. However, these mice are not intrinsically secretion deficient. By crossing the RF transgenic mice with the autoimmune MRL/lpr background, we find a dramatic increase, > 200-fold, in levels of serum RF. The results strongly suggest that a major function of normal resting RF B cells is unrelated to antibody secretion. Rather, the RF B cells in the follicles may play a role in antigen presentation and regulation of immune responses to antibody-bound nonself-, and possibly self-antigens. This physiologic role of RF B cells may be disrupted in RF-associated autoimmune disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8418195      PMCID: PMC2190869          DOI: 10.1084/jem.177.1.109

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  40 in total

1.  Antigen presentation by resting B cells. Effectiveness at inducing T cell proliferation is determined by costimulatory signals, not T cell receptor occupancy.

Authors:  M K Jenkins; E Burrell; J D Ashwell
Journal:  J Immunol       Date:  1990-03-01       Impact factor: 5.422

Review 2.  Are B lymphocytes the principal antigen-presenting cells in vivo?

Authors:  J D Ashwell
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

3.  Intraclonal diversity in the VH genes expressed by CD5- chronic lymphocytic leukemia-producing pathologic IgM rheumatoid factor.

Authors:  J Roudier; G J Silverman; P P Chen; D A Carson; T J Kipps
Journal:  J Immunol       Date:  1990-02-15       Impact factor: 5.422

4.  Early restriction of the human antibody repertoire.

Authors:  H W Schroeder; J L Hillson; R M Perlmutter
Journal:  Science       Date:  1987-11-06       Impact factor: 47.728

5.  Induction of self-tolerance in mature peripheral B lymphocytes.

Authors:  C C Goodnow; J Crosbie; H Jorgensen; R A Brink; A Basten
Journal:  Nature       Date:  1989-11-23       Impact factor: 49.962

6.  Expression of anti-DNA immunoglobulin transgenes in non-autoimmune mice.

Authors:  J Erikson; M Z Radic; S A Camper; R R Hardy; C Carmack; M Weigert
Journal:  Nature       Date:  1991-01-24       Impact factor: 49.962

7.  Rheumatoid factor and immune networks.

Authors:  D A Carson; P P Chen; R I Fox; T J Kipps; F Jirik; R D Goldfien; G Silverman; V Radoux; S Fong
Journal:  Annu Rev Immunol       Date:  1987       Impact factor: 28.527

8.  Isolation and characterization of a light chain variable region gene for human rheumatoid factors.

Authors:  P P Chen; D L Robbins; F R Jirik; T J Kipps; D A Carson
Journal:  J Exp Med       Date:  1987-12-01       Impact factor: 14.307

9.  Efficient and selective presentation of antigen-antibody complexes by rheumatoid factor B cells.

Authors:  E Roosnek; A Lanzavecchia
Journal:  J Exp Med       Date:  1991-02-01       Impact factor: 14.307

10.  Uniform high frequency expression of autoantibody-associated crossreactive idiotypes in the primary B cell follicles of human fetal spleen.

Authors:  T J Kipps; B A Robbins; D A Carson
Journal:  J Exp Med       Date:  1990-01-01       Impact factor: 14.307

View more
  12 in total

Review 1.  Antigen-presenting cells in rheumatoid arthritis.

Authors:  R Thomas
Journal:  Springer Semin Immunopathol       Date:  1998

2.  Peripheral deletion of rheumatoid factor B cells after abortive activation by IgG.

Authors:  H Tighe; K Warnatz; D Brinson; M Corr; W O Weigle; S M Baird; D A Carson
Journal:  Proc Natl Acad Sci U S A       Date:  1997-01-21       Impact factor: 11.205

Review 3.  Biological therapies directed against cells in autoimmune disease.

Authors:  Paul Hasler
Journal:  Springer Semin Immunopathol       Date:  2006-04-28

4.  Differential requirements for induction of total immunoglobulin and physiological rheumatoid factor production by human peripheral blood B cells.

Authors:  W J Van Esch; C C Reparon-Schuijt; E W Levarht; C Van Kooten; F C Breedveld; C L Verweij
Journal:  Clin Exp Immunol       Date:  2001-03       Impact factor: 4.330

Review 5.  To B or not to B the conductor of rheumatoid arthritis orchestra.

Authors:  Rita A Moura; Luis Graca; João E Fonseca
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

6.  Methotrexate attenuates the Th17/IL-17 levels in peripheral blood mononuclear cells from healthy individuals and RA patients.

Authors:  Yanshan Li; Lindi Jiang; Si Zhang; Lianhua Yin; Lili Ma; Dongyi He; Jie Shen
Journal:  Rheumatol Int       Date:  2011-06-21       Impact factor: 2.631

7.  Persistence of a rheumatoid factor (RF)-producing B cell clone with a somatically mutated Ig kappa chain in a patient with rheumatoid arthritis.

Authors:  A Schrauder; A Gause; W Jung; R Mierau; M Pfreundschuh
Journal:  Clin Exp Immunol       Date:  1994-08       Impact factor: 4.330

8.  Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis.

Authors:  W Palinski; E Miller; J L Witztum
Journal:  Proc Natl Acad Sci U S A       Date:  1995-01-31       Impact factor: 11.205

9.  VH3-21 B cells escape from a state of tolerance in rheumatoid arthritis and secrete rheumatoid factor.

Authors:  X He; J J Goronzy; W Zhong; C Xie; C M Weyand
Journal:  Mol Med       Date:  1995-11       Impact factor: 6.354

Review 10.  Autoantibodies in rheumatoid arthritis: rheumatoid factors and anticitrullinated protein antibodies.

Authors:  Y W Song; E H Kang
Journal:  QJM       Date:  2009-11-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.